Skip to content

Amgen AMGN Interest Expense

Interest Expense at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$12.9M+48.3%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$39.9M+25.7%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$12.2M
Johnson & Johnson logo
Johnson & JohnsonJNJ
$272M+33.3%
United Therapeutics logo
United TherapeuticsUTHR
$3M-50.8%
ALN
Alnylam PharmaceuticalsALNY

Segments

By segment

See full
Reportable Segment$657M-9.1%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$182.21B+13.3%
Enterprise value$238.97B+9.9%
P/E23.4×-3.7×
P/S4.9×+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseDebt.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's interest expense?
Amgen (AMGN) reported interest expense of $657M in Q1 2026.
How has Amgen's interest expense changed year-over-year?
Amgen's interest expense decreased by 9.1% year-over-year, from $723M to $657M.
What is the long-term trend for Amgen's interest expense?
Over 4 years (2021 to 2025), Amgen's interest expense has grown at a 23.2% compound annual growth rate (CAGR), from $1.2B to $2.76B.